Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine supplementation for cystic fibrosis
2007-006204-37Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of glutamine in cystic fibrosis (CF) (2 arms), sponsored by University of Nottingham. Primary endpoints: Change in sputum markers of inflammation and Change in lung function. Started May 2008; status: completed.
02
Drugs
glutamine
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2007-006204-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006204-37.